News & Analysis on Clinical Trial Services & Contract Research And Development
Sourcing comparator drugs for trials is a complex ‘art’ that requires knowledge of trading, regional regulations and an awareness of drugmakers’ competitive concerns according to Clinigen Group CEO Peter George.
Analysts have raised their targets for Parexel in light of progress with Pfizer and other growth drivers for 2012.
Ideal Cures has been granted a US patent for an immediate release film coating tech that - it claims - could rid the Pharma production sector of solvents.
More than four-fifths of anti-malarials sampled in Nigeria failed to meet USP specifications for one of the APIs, researchers found.
Novasep says it may invest in active pharmaceutical ingredients (API) bioproduction and purification technology citing growing industry demand.
UTi Worldwide reported higher pharmaceutical volumes in the fourth quarter on new business wins and increased client activity.